Tag: Evotec

Oxford

LAB282 – a Unique Partnership Supporting Innovation from Academic Research

LAB282 is a new funding partnership in Oxford, which has just awarded its first grants. We interviewed Dr Thomas Hanke, Expert in Residence at LAB282 and Head of Academic Partnerships at Evotec. Read on to find out what is so unique about LAB282, what it can offer and, most importantly, how to get them toaaa

Read more
Oxford

Evotec AG: LAB282 awarded first projects

Oxford University and Evotec’s drug discovery partnership launched last November to accelerate drugs to market begins making awards. Hamburg, Germany, 21 February 2017: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) is pleased to announce that LAB282, the £13m drug discovery partnership with Oxford University, has made its first wave of awards, backing projectsaaa

Read more
Oxford
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.